Počet záznamů: 1  

Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions

  1. 1.
    0551597 - FGÚ 2022 RIV CH eng J - Článek v odborném periodiku
    Obšilová, Veronika - Honzejková, K. - Obšil, Tomáš
    Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions.
    International Journal of Molecular Sciences. Roč. 22, č. 24 (2021), č. článku 13395. E-ISSN 1422-0067
    Grant CEP: GA ČR(CZ) GA19-00121S; GA ČR(CZ) GA20-00058S
    Institucionální podpora: RVO:67985823
    Klíčová slova: ASK1 * phosphorylation * MAP kinase * 14-3-3 * kinase * protein–protein interaction
    Obor OECD: Biochemistry and molecular biology
    Impakt faktor: 5.923, rok: 2020
    Způsob publikování: Open access
    https://www.mdpi.com/1422-0067/22/24/13395

    Apoptosis signal-regulating kinase (ASK) 1, a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, modulates diverse responses to oxidative and endoplasmic reticulum (ER) stress and calcium influx. As a crucial cellular stress sensor, ASK1 activates c-Jun N-terminal kinases (JNKs) and p38 MAPKs. Their excessive and sustained activation leads to cell death, inflammation and fibrosis in various tissues and is implicated in the development of many neurological disorders, such as Alzheimer’s, Parkinson’s and Huntington disease and amyotrophic lateral sclerosis, in addition to cardiovascular diseases, diabetes and cancer. However, currently available inhibitors of JNK and p38 kinases either lack efficacy or have undesirable side effects. Therefore, targeted inhibition of their upstream activator, ASK1, stands out as a promising therapeutic strategy for treating such severe pathological conditions. This review summarizes recent structural findings on ASK1 regulation and its role in various diseases, highlighting prospects for ASK1 inhibition in the treatment of these pathologies.
    Trvalý link: http://hdl.handle.net/11104/0326849

     
     
Počet záznamů: 1